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Abstract 
Single crystals of salmeterol xinafoate (form I), prepared from slow cooled supersaturated propan-2-ol 
solutions, crystallise in a triclinic P1 symmetry with two closely related independent salt pairs within the 
asymmetric unit, with an approximately double unit cell volume compared to the previously published crystal 
structure1. Synthonic analysis of the bulk intermolecular packing confirms the similarity in packing energetics 
between the two salt pairs. The strongest synthons, as expected, are dominated by coulombic interactions. 
Morphological prediction reveals a plate-like morphology, dominated by the {001}, {010} and {100} surfaces, 
consistent with experimentally grown crystals. Though surface chemistry of the slow growing {001} face comprises 
of large sterically hindering phenyl groups, weaker coulombic interactions still prevail from the alcohol group 
present on the phenyl and hydroxymethyl groups. The surface chemistry of the faster growing {010} and {100} 
faces are dominated by the significantly stronger cation/anion interactions occurring between the carboxylate and 
protonated secondary ammonium ion groups. The importance of understanding the cohesive/adhesive nature of the 
crystal surfaces of an API, with respect to their interaction with other API crystals and excipients and how that may 
impact formulation design is highlighted. 
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Ecr = Lattice energy 
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DSC = Differential scanning calorimetry 
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Introduction  
Salmeterol Xinafoate (2-(hydroxymethyl)-4-[1-hdyroxy-2-[6-(4-(phenylbutoxy) hexylamino] ethyl] phenol, 1-
hydroxynaphthalene-2-carboxylic acid (SX)) is a long-acting β2-adrenoceptor agonist. It is commonly used on its 
own, or in combination with fluticasone propionate, for treating asthma. This material is present as the active 
pharmaceutical ingredient (API) in Serevent Diskus©, (GlaxoSmithKline).  
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SX is a salt that can exist in two crystalline polymorphic forms that exhibit an enantiotropic relationship, with form I 
being the stable polymorph and form-II being the metastable polymorph at ambient conditions 2,3. Thermal studies 
of Salmeterol Xinafoate by Beach et al. observed that melting endotherms occurred at 122.7 °C and 137.6 °C, which 
were attributed to the melting of form I and form II respectively. Previous studies have suggested that the high 
contact temperatures induced by the milling process can produce seeds of form II, which are thought to then initiate 
the observed polymorphic transformation from form I to form II4-8. As a caveat to this, Beach et al. also showed that 
highly pure crystals of form I, prepared by solution enhanced dispersed supercritical fluids, did not show any 
significant evidence of polymorphic conversion, perhaps reflecting the absence of any form II seeds whilst using this 
process. This may suggest that the transformation kinetics between form I and form II are very slow. Although the 
crystallisation methods to obtain form I have been well described in the literature2,4,5,9,10, the challenges associated 
with the preparation and isolation of a required size single crystal for single crystal X-ray diffraction (XRD) have, so 
far, resulted in the crystal structure solution from powder XRD data1, the latter revealing apparent significant 
disorder around the phenyl group. 
Servent Diskus© is marketed as an inhalation formulation, containing micronised drug particles that tend to form 
agglomerates with the carrier particles (excipients), and therefore must be effectively dispersed upon inhalation for 
optimum therapeutic value. To ensure effective dispersion, the balance between the cohesive (between 
homogeneous particles in the formulation) and adhesive (between heterogeneous particles in the formulation) forces 
is vital in the formulation design11,12.  
Crystallographic and molecular modelling, utilising the atom-atom approach, has been extensively exploited to 
predict crystal morphologies13-20 and identify the important bulk (intrinsic) and surface (extrinsic) intermolecular 
interactions (synthons), which can stabilise the crystal packing and influence face-specific crystal growth21-23. In 
formulation design, one or more excipients are selected for addition to the API. Excipients range from a lubricant to 
a bulking or a flavour enhancing agent. Excipients also play a major part in the stability and bioavailability of the 
drug and hence the key challenge is to choose the right excipient(s) for the API24-26. This can be achieved by 
identifying and classifying the API’s extrinsic synthons. Knowledge of such interactions is helpful to assess API’s 
binding to excipients (adhesive) or themselves (cohesive).  
In the case of inhalation formulations, the micronised ingredients provide higher specific surface areas, resulting in 
increased van der Waals, electrostatic and capillary interactions. Hence they tend to form agglomerates thus 
exhibiting strong cohesion between homogeneous particles and adhesion between heterogeneous particles26,27. The 
balance of cohesion and adhesion will have an effect on the content uniformity in the formulation and the 
dispersibility in the lungs after inhalation. Therefore the understanding of the cohesive-adhesive balance is critical 
both in the formulation design as well as the product performance and bioavailability28,29. In a recent study, the 
cohesive-adhesive balance between the API and excipients of inhalation powders (fluticasone propionate, 
budesonide and salbutamol11,12) was investigated using molecular and crystallographic modelling tools. These 
simulations were successfully correlated to de-agglomeration data measured by laser diffraction30 and highlights the 
applicability of this method to guide the formulation design of such inhalation powders, to achieve optimum 
efficacy. However, the application of these tools requires a crystal structure with well-resolved atom positions, along 
with an understanding of the bulk crystal and surface chemistry associated with the structure. 
This paper reports the crystal structure of the form I of Salmeterol Xinafoate, as obtained using single crystal 
XRD data. Based on this, the intermolecular packing energetics, morphology and the surface chemistry of the 
morphologically important surfaces were characterised. 
Materials and Methods 
Materials 
A supply of micronised SX was acquired from Vamsi Labs Ltd. (Chincholi, Solapur, Maharashtra, India) with 
batch number SX-0030513.  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
3 
 
Crystal Growth and Characterisation 
Single Crystal Growth 
Salmeterol xinafoate single crystals were crystallised using a method based on a study presented by Murnane et al. 4. 
A 1.6 w/v% suspension of SX was prepared. 10mg of SX was added to 0.625ml of propan-2-ol. This was then 
heated to 60 °C and stirred for 30 minutes. After maturing overnight at 45 °C it was then further cooled to 22 °C 
over 24 hours. The final suspension was filtered under vacuum and dried off in a desiccator for a further 24 hours. 
This method produced crystals of the size (50-250µm) and quality required to analyse by single crystal XRD. 
Optical Microscopy 
An Olympus BX51, set in transmission mode utilising cross polarisation, with a UMPlanFl 10x/ 0.30 
objective was utilised to analyse the size and shape of the crystals grown. The field and aperture diaphragms 
were adjusted to ensure optimum contrast and depth of field. QCaptureProV6.1. was used for measurements 
of the length and the width of the crystal. 
Differential Scanning Calorimetry (DSC) 
The thermal profiles were produced using a Mettler Toledo DSC1. Approximately 1.5mg of the micronised 
and single crystal SX samples were weighed out into 40 µL alumina pans (Mettler Toledo). Samples were 
heated from 25 to 200 °C, with a rate of 2 ° Cmin-1, and repeated to check for reproducibility.  
Single Crystal X-Ray Diffraction  
A suitable single crystal was immersed in inert oil and mounted on a nylon loop. The crystal was then cooled 
to 120 K using an Oxford Cryosystems 700 Series Crysostream Cooler31 and data collected on a 
RigakuSuperNova diffractometer fitted with an Atlas CCD detector with monochromated Mo-Kα radiation (λ 
= 0.71073 Å). The dataset was collected and processed using CrysAlisPRO32 and corrected for absorption 
using an analytical numeric correction33; the structure solved using SHELXS34 and refined by full-matrix least 
squares on F2 using ShelXL-201435 interfaced through the programme Olex236. Molecular graphics and tables 
of data were produced using Olex236. All non-hydrogen atoms were located in the Fourier Map and refined 
anisotropically. All hydrogen atoms bound to carbon were placed in calculated positions and refined 
isotropically using a “riding model”.  
Computational Analysis 
The computational analysis was carried out utilising Mercury37, HABIT9838 and Accelrys software Materials 
Studio39 (MS). Structural optimisation, through lattice energy minimisation, was performed in MS utilising the 
Forcite module, Dreiding forcefield40 and Gasteiger charges41.  The conformation was allowed to relax whilst 
maintaining periodicity, and the unit cell parameters were held rigid. 
The strength and nature of the intermolecular synthons, the lattice energy (Ecr) and hence the slice (Esl) and 
attachment (Eatt) energies, were calculated within HABIT98 using the potential parameters published by Momany et 
al42, with the Evjen summation method43 to ensure charge neutrality. The former is particularly appropriate for 
modelling organic crystals containing amide and carboxylic acid groups42. The programme creates a nest of unit 
cells in three dimensions and calculates all the interactions within a user-defined sphere. The lattice energy was 
calculated at sphere radii between 10-115 Å to test and ensure convergence of the lattice energy.  
The intermolecular synthons contributing to the lattice energy was divided into slice and attachment energies, 
according to Equation 1.  
 = 	 +  (Equation 1) 
The attachment energies were scaled as relative growth rates per surface and used to construct a Wulff plot44 within 
Mercury to predict the crystal morphology.  
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The surface anisotropy factor () was calculated to assess the degree of synthon broken upon surface termination 
of the bulk crystal chemistry, with respect to the resultant surface chemistry45,46, using Equation 2.  
 =



 (Equation 2) 
All anisotropy factors were given as a percentage. 
The methodologies associated with the ranking of the intermolecular synthons and the lattice energy breakdown 
have been described in previous publications21,30. The contribution of the functional groups to the lattice energy was 
calculated by summing the individual constituent atom contributions to the lattice energy, calculated in HABIT98. 
All visualisation of molecular and crystal packing was carried out in Mercury and Materials Studio. 
Results and Discussion 
Crystal Growth and Characterisation 
The solution grown crystals were formed with good optical quality and displayed a plate-like morphology, with 
sizes ranging from 57-200µm along the longest axis. One of the largest crystals is shown in Figure 1(a).  
Figure 2 shows the DSC profiles of the as received micronised sample (plotted as dashed) and the re-crystallised 
sample (plotted as solid). The micronised sample revealed two endotherms, in good agreement with the previously 
published melting points for form I and form II2, along with an exotherm at ~128 °C, which can be attributed a re-
crystallisation event which is consistent with the polymorphic transformation from form I to form II2. In 
comparison, the re-crystallised sample showed a much lower peak intensity for the latter transformation, suggesting 
a much lower concentration of form II. This data is in good agreement with previous studies2. 
Crystallographic data from the single crystal XRD has been tabulated in Table 1. Form I was found to 
crystallise in a centrosymmetric triclinic structure (space group P1) with a tetra-molecular unit cell (Z=2, 
Z’=4), with two crystallographically independent anion/cation pairs of salmeterol and xinafoate, labelled 
SA1, SA2, XI1 and XI2. Hydrogen atoms bound to heteroatoms (O, N) were located in the Fourier Map and 
refined isotropically, apart from O3A,B, which were placed in calculated positions. The packing of the unit 
cell is illustrated in Figure 3a, with the different colours referring to the symmetrically equivalent ions from 
the asymmetric unit. The packing of molecules in Figure 4 shows that the major H-bonds and anion-cation 
interactions are orientated closest to the a and b axes directions with less of these interactions being 
orientated close to the c-axis direction. An examination of the differences in the Fourier Map of the electron 
density revealed the presence of some disorder within the crystal structure, specifically the nature of disorder 
between two salmeterol molecules. SA1 exhibited residual electron density, consistent with the alcohol group 
being disordered between two positions, with both S (major) and R (minor) isomers being present. The 
occupancies of the oxygen atoms were refined to 90% and 10% (S and R respectively). C-O bond lengths 
were restrained to 1.430 (5) Å and O3B (minor component) was refined isotropically to ensure stable 
refinement. Blue circles on Figure 3b highlights the position of the disorder.  
The SA2 molecule exhibited slightly more disorder on the (CH2)3(C6H5) groups across these two positions, 
with the occupancies of the two components being refined to 70% and 30% respectively. An enhanced rigid-
bond restraint (RIGU)47 was applied to the anisotropic displacement parameters of the minor disordered 
component to obtain more sensible parameters than could be obtained without using this technique. Blue 
circles on Figure 3c highlights the position of the disordered molecular groups on the salmeterol cations. 
Based on the disorder positions refined from the single crystal XRD, the dominant atomic positions (90% occupancy 
of the oxygen atom of the alcohol group of SA1 and 70% occupancy of the (CH3)2(C6H5) on SA2) were taken 
forward for the intermolecular energetics, morphology and surface chemistry calculations. Coordinates of the 
disordered functional group components have been tabulated in Supplementary Material. 
Conformational Analysis  
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The presence of the two salt pairs within the asymmetric unit was found to reflect the conformational 
difference of the salmeterol ions. Figure 5b highlights the differences between the two salmeterol ions, 
revealing that the main conformational change occurs due to rotation of the C-C bond that is adjacent to the ether 
group on SA2, of around ~ 107 º. This results in a significant difference in orientation for the phenyl ring between 
the two salmeterol ions (Figure 5a). As might be expected, there was no significant difference in conformation 
between the xinafoate ions.   
Comparison to Previous Structure 
The cell parameters of form I are listed in Table 2 (Structure in CCDC, 1483119)  and compared with the previously 
published powder XRD parameters1. The cell parameter along the b axis, which was 9.484 Å from the powder 
XRD1, was found to be extended to almost double that value, at 16.122 Å from the single crystal XRD structure. 
The previous structure1 showed packing of crystallographically equivalent salmeterol and xinafoate ions along the b-
axis. However, the identification of the two crystallographically independent salt pairs within the asymmetric unit 
effectively doubles the unit cell vector along the b-axis.  
The previous structure1 showed a disorder around the phenyl ring of the salmeterol ion, which was modelled, in that 
study, using a thermal ellipsoid to account for the uncertainty.  A comparison of the packing arrangement of the 
two structures does though reveal the same network of hydrogen bonding interactions, indicating a broad 
consistency of the solid state structures.  
Key Intermolecular Synthons in Solid State  
The lattice energy converged to -67.75kcal/mol (Figure 6) at a greater limiting radius, when compared to previous 
studies of molecular crystals21,48. The latter probably reflects the fact that the coulombic interactions, between the 
charged species, are much longer range than van der Waals (vdW) or hydrogen bonding interactions (H-bonds). 
Figure 6 also shows that the coulombic interactions (red line) accounted for almost half of the lattice energy. Figure 
7 shows diagrammatically how the constituent molecular fragments of the salt pair contribute to the calculated 
lattice energy. The summation of the atom and functional group contributions revealed that the COO- (δ) group had 
the greatest contribution to the calculated lattice energy, reflecting its intimate involvement with the strong 
coulombic anion-cation interactions. Groups β and γ were found to have similar contributions. However it is likely 
that group β will have more directional interactions due to the charged atoms within this group, along with the 
interactions being focussed onto significantly fewer atoms than group γ. Groups α and ε, which are dominated by the 
aromatic ring structures, were found to contribute less to the calculated lattice energy than the other groups. This 
perhaps reflects the fact that the packing considerations for large molecules, such as salmeterol, can preclude the 
close alignment of the aromatic groups and hence the kind of strong pi-pi stacking interactions that have been 
observed within the crystal structures of smaller aromatic molecules21,49,50, which can contribute more significantly 
to the lattice energy. 
Table 3a shows the top twelve strongest attractive synthons found from the analysis of the bulk crystal structure. All 
of the most attractive synthons were found to be between the anion-cation pairs, reflecting the dominant interactions 
resulting from the coulombic forces. Also, due to the symmetrical inequivalencey of the salt pairs, the synthon types 
were often found to be very similar to each other and simply occurring between the different symmetrically 
inequivalent ions. This is indicated in column 2 of Table 3, which identifies the ions that make up the synthon; along 
with Figure 8, which shows the molecular orientation of the strongest synthon types. 
Figure 8 reveals that the orientation of the specific atoms strongly influences the strength of the synthon. Synthons 
Aa/Ba have the closest orientation of the oppositely charged COO- and NH2+, resulting in a very strong coulombic 
interaction. This synthon contained a H-bonding network consisting of one intra and two intermolecular H-bonds, 
due to the close proximity of the donor H’s on the NH2+ group and acceptor O’s on the COO- group. The added 
attractive force of these H-bonds probably contributes to this synthon being calculated as the most attractive within 
the structure. However, the calculations indicated that the majority of the energy of this synthon is still produced by 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
6 
 
the electrostatic interactions between the oppositely charged atoms. It was also observed that, in general, as the 
distance between the COO- and NH2+ groups increases, the attractive force between the ions decreases. However, 
even though the COO- and the NH2+ groups are closer in synthon La, synthons Ia/Ka and Ja were calculated to have a 
greater attractive interaction due to these synthons forming greater vdW and H-bonding interactions respectively.  
Though the two ions have six H-bond donor atoms and eight H-bond acceptor atoms between them, the only other 
synthon to have a significant H-bond is Ja, where the COO- group of the xinafoate ion is orientated close to the OH 
group which is directly on the phenyl ring of salmeterol. This indicates that the H-bonding probably doesn’t 
influence the stability of this crystal structure as much when compared to how it can affect the stability of a small 
molecule molecular crystal21,51,52. The combination of the strong electrostatic interactions and the fact that salmeterol 
has relatively large molecular weight (603.745 g/mol), which gives it a greater capacity to form stronger vdW 
interactions, has probably resulted in the decreased influence of H-bonds on the stability and physical properties of 
this structure. 
The strongest repulsions within the crystal structure were found to be between the anionic xinafoate ions, shown in 
Figure 9. Due to the symmetrical equivalence of the anions, the most repulsive four independent pairs are illustrated. 
Table 3b shows that, as expected, the majority of the repulsion energy is due to the coulombic repulsions. These 
repulsive synthons were found to be between 7.17 Å and 9.57 Å apart (carbonyl C-carbonyl C). These repulsions 
were more than compensated for by the strong attractive forces between the anion-cation pairs. Hence the crystal 
structure was found to be stable, even in the presence of these repulsions.  
Morphology and Surface Chemistry 
Figure 1b shows that the predicted morphology compares well with the experimental data (Figure 1a). However the 
observed crystal has a greater aspect ratio than the predicted morphology. The cleaved {100}, {010} and {001} 
surfaces are shown in Figure 1b. The top three extrinsic synthons that are contributing to the attachment energies of 
each plane are tabulated in Table 4. The {001} surface was calculated to have an attachment energy of -
4.51kcal/mol, hence being predicted to be the slowest growing surface. The strongest bulk attractive synthons lay 
within the slice, and as such the terminal functional groups on the surface that would be expected to influence the 
growth are large sterically hindering phenyl from SA1 and alcohol group extended from the phenyl group from SA2. 
Table 4 reveals that the strongest synthon that contributes to the attachment energy of the {001} surface had an 
energy of -5.32kcal/mol, which is much less than the energies of the strongest synthons that are shown in Table 3. 
These synthons were both found to be mainly dominated by the COO---- NH2 interactions as well as COO- --- OH 
present on the phenyl ring. 
In contrast, the {010} plane was predicted to be the fastest growing with an attachment energy of -24.78 kcal/mol, 
which was attributed to the position of the terminal anion, allowing for a much greater electrostatic attraction at the 
surface and thus growth in the given direction. Table 5 shows that synthon Ba has the highest contribution to the 
attachment energy of the {010} surface, at -29.94 kcal/mol. The dominant interaction within this synthon is based on 
the strong coulombic interactions between the salt pairs. Similarly, the synthons containing the strong coulombic 
interactions between the salt pairs were also predicted to contribute strongly to the attachment energy of the {100} 
surface. Hence this is also predicted to be much faster growing and smaller than the dominant {001} surface. 
The % surface saturation (anisotropy factors) are shown in Table 4. As expected, the {001} surface contains the 
highest degree of saturation, 93.4%, due to less of the strong synthons being broken at the surface. In comparison the 
{010} and {100} surfaces which have 64.41% and 65.52% saturation respectively, as they are predicted to have 
strong anion/cation synthons broken at their respective surfaces. Due to the higher degree of unsaturation, it can be 
expected from a formulation design perspective, that the edges of the crystals will have cohesively higher binding 
affinity than for the larger more dominant facets. This has been observed in previous studies of the crystallisation 
behaviour of paracetamol crystals53-55, where the crystals appeared to agglomerate through the binding of the smaller 
side, rather than the large flat, stable surface. The latter might suggest why micronised APIs are often preferred in 
the practical formulation, since the majority of the natural surface of the as-grown single crystals of this compound 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
7 
 
may be expected to show poor adhesivity and cohesivity to excipients and other API crystals respectively. The 
micronisation procedure can be expected to lower the surface energy of the crystal surfaces27,56-59, by exposing 
higher energy fracture planes, which can exhibit lower degrees of synthon saturation with much greater potential for 
surface bonding60, and as such, this probably improves the adhesive behaviour of the API. 
Conclusion 
The re-crystallisation and characterisation of Salmeterol Xinafoate form I has been carried out revealing a 
crystal structure that contains two crystallographically independent salt pairs, associated with conformational 
differences between the two salmeterol ions. This provides an update and further refinement on the previous 
structure that predicted only one salt pair within the asymmetric unit. Synthonic modelling revealed the 
extent of the importance of coulombic interactions between the salt pairs to stabilise the lattice energy, and 
suggested that even though there are H-bonds within the crystal structure, their influence is much reduced in 
salt structures when compared to lower molecular weight crystal structures. The prediction of a crystal 
morphology containing three major faces was consistent with the general shape observed from solution grown 
crystals, whereby the slowest growing and dominant {001} surface does not have any of the strong coulombic 
synthons broken at the surface. In contrast, the faster growing {010} and {100} surfaces were predicted to 
have many more of the strong synthons broken at the surface. The poor adhesivity of the large {001} surface 
might be consistent with the salmeterol xinafoate based products being formulated with micronised API 
powders due to the crystal fracture revealing new habits with a high potential for surface binding related to 
the lower degree of saturated synthons. This suggests that the type of analysis presented here might have 
more general applications in the formulation design of other API’s, to mitigate cases where the as-grown 
crystals show poor adhesion behaviour with excipients. 
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Table 1: Crystallographic Data for Salmeterol Xinafoate from single crystal X-ray diffraction.  
Empirical formula  C36H45NO7  
Formula weight  603.73  
Temperature/K  120.0(2)  
Crystal system  triclinic  
Space group  P1  
a/Å  9.3848(4)  
b/Å  16.1229(6)  
c/Å  21.2091(10)  
α/°  90.156(4)  
β/°  97.687(4)  
γ/°  93.561(4)  
Volume/Å3  3174.0(2)  
Z  4  
ρcalcg/cm3  1.263  
Crystal size/mm3  0.37 × 0.13 × 0.04  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.234 to 62.584  
Reflections collected  48367  
Goodness-of-fit on F2  1.053  
Final R indexes [I>=2σ (I)]  R1 = 0.0750, wR2 = 0.1351  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Unit cell parameters comparing the previously published structure and newly proposed 
structure.  
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Table 3a:  Strength of top 12 most attractive (top, with subscripted a and illustrated in Figure 8) and 6 
most repulsive synthons (bottom, with subscripted r and illustrated in figure 9) along with the 
molecules involved within the synthons. Distances quoted are the distances between the two centres 
of gravity of the ions.  
A: 
Parameters Previously published structure1 This Work 
a  (Å) 9.1738(9) 9.3848(4) 
b  (Å) 9.4837(9) 16.1229(6) 
c  (Å) 21.366(6) 21.2091(1) 
α (°) 82.264(6) 90.156(4) 
β (°) 85.253(1) 97.687(4) 
γ (°) 62.156(5) 93.561(4) 
Volume (Å3) 1628.3(6) 3174.0(2) 
Z 4 2 
Z’ 2 4 
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Synthon Molecules 
Involved 
Inter Ion 
Distance (Å) 
Coulombic 
Contribution 
(kcal/mol) 
Total Interaction 
(kcal/mol) 
Aa SA2/XI2 5.43 -27.94 -30.15 
Ba SA1/XI1 5.58 -27.28 -29.94 
Ca SA1/XI1 9.64 -18.72 -21.36 
Da SA2/XI2 10.10 -18.19 -20.90 
Ea SA2/XI2 5.24 -12.17 -15.29 
Fa SA1/XI1 5.64 -11.84 -14.99 
Ga SA2/XI1 8.23 -8.60 -12.04 
Ha SA1/XI2 8.98 -8.61 -11.42 
Ia SA1/XI2 8.18 -10.52 -10.75 
Ja SA2/XI1 16.71 -9.26 -10.66 
Ka SA2/XI1 8.76 -10.34 -10.54 
La SA1/XI1 11.34 -9.69 -9.75 
B: 
Synthon Molecules 
Involved 
Inter Ion 
Distance (Å) 
Coulombic 
Contribution 
(kcal/mol) 
Total Interaction 
(kcal/mol) 
Ar XI1/XI1 12.35 14.57 14.52 
Br XI2/XI2 12.25 14.55 14.50 
Cr XI1/XI2 8.80 9.29 9.18 
Dr XI1/XI2 9.35 9.12 9.05 
Er XI1/XI2 9.77 9.12 9.02 
Fr XI2/XI2 9.39 9.02 8.92 
 
 
 
 
 
Table 4: Slice and attachment energies calculated for the morphologically important surfaces of form 
I, which were used to construct a prediction of the crystal morphology (Figure 1(b)) 
Lattice Energy -67.75 
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(kcal/mol) 
Surface Slice Energy 
(kcal/mol) 
Attachment Energy 
(kcal/mol) 
Surface 
Saturation % 
{001} -63.90 -4.51 94.32 
{010}] -43.64 -24.78 64.41 
{01-1} -44.39 -24.03 65.52 
{100} -48.19 -20.23 71.13 
{10-1} -39.13 -29.29 57.76 
{1-10} -38.05 -30.37 56.16 
{1-1-1} -31.92 -36.49 47.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Showing the top three extrinsic synthon contribution from the different major planes, their 
labels corresponding to the bulk synthons shown in Table 3a. *Most attractive synthon contributing to 
the lattice energy was found to be outside the top 12 bulk attractive synthons 
Surface Synthon Molecules Distance (Å) Columbic Total Interaction 
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Involved (kcal/mol) Energy (kcal/mol) 
(001) * SA2/XI1 13.69 -4.24 -5.32 
* SA1/XI2 14.26 -4.23 -5.22 
* SA2/XI2 12.65 -4.95 -4.98 
(100) Ba SA1/XI1 5.58 -27.28 -29.94 
Ea SA2/XI2 5.24 -12.17 -15.29 
La SA1/XI1 11.34 -9.69 -9.75 
(010) Ba SA1/XI1 5.58 -27.28 -29.94 
Fa SA1/XI1 5.64 -11.84 -14.99 
Ia SA1/XI2 8.18 -10.52 -10.75 
 
 
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
Figure 1(a): SX single crystal with a length of 200µm under dual polarised transmitted 
mode microscope. Small fractures and debris from other crystals can be observed on 
the top surface of the crystal.  
(b): Attachment energy morphological prediction showing a plate-like morphology with the 
{001} being the dominant face, along with the smaller {010} and {100} surfaces. The 
terminating functional groups (surface chemistry) that dominate each of the faces are shown 
in (c, d, e). These functional groups are enlarged in squares.  
Figure 2: DSC thermal profiles. The dashed trace is of the recrystallised material 
and shows only one major melting event at approximately 125°C and a small 
bump at approximately 137°C. The solid trace is of the as received micronized material and 
shows two major melting points and a polymorph transition event. 
Figure 3(a): The P1 triclinic unit cell of salmeterol xinafoate form I solved by single crystal 
XRD. The colouring indicates the symmetrically equivalent molecules found in the unit cell. 
The legend; SA1, SA2, XI1 and XI2 notating the four molecules present in the asymmetric 
unit; (b) the first pair of salmeterol and xinafoate ions, coloured green and red in the unit cell; 
(c) the second pair of salmeterol and xinafoate ions, coloured blue and yellow in the unit cell. 
The disorder positions are shown within the blue circles. 
Figure 4: Packing of the salmeterol xinafoate form I structure demonstrating that the strong 
interactions between the oppositely charged ions and the H-bonds run closest to parallel to 
the a and b axes, and less along the direction of the a-axis.  
Figure 5(a): Overlays of the two salmeterol conformers (SA1 and SA2). Main difference in 
conformation is the rotation of the (CH2)3(C6H5) groups (circled); (b): Torsional angle at the 
centre of major rotation between the two salmeterol molecules, along the O4-C16-C17-C18 (-
178.986°) and O11-C52A-C53A-C53A-C54A (72.127°), which results in the two separate 
conformers. 
Figure 6: Lattice energy convergence as a function of limiting radius for SXI, indicating that 
interactions above approximately 30 Å are relatively unimportant to the stabilisation of the 
lattice. 
Figure 7: The % contribution to the lattice energy from the different molecular groups of the 
asymmetric unit. The percentages are summed from all four molecules of the asymmetric unit 
and collapsed onto the molecular structure of the two molecules for simplicity. The 
contributions of the salt pairs were found to be broadly similar and were therefore averaged. 
Figure 8: Molecular orientation of the top 12 attractive synthons shown in Table 2a, 
indicating that the major interactions were between the oppositely charged ions. Similar 
interaction types that are only different since they are between the different salt pairs are 
shown only once and labelled as two synthons. H-bonding synthons enlarged for clarity of H-
bonding atoms. All distances are quoted between COO- -- NH2+. 
Figure 9: Molecular orientation of the top 4 repulsive synthons shown in Table 3b, indicating 
that the major repulsions were between the xinafoate ions. All distances are quoted between 
C-C atoms. 
.
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